| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Tales from the Corporate Frontlines: The Worth of Health Insurance |
|
Advice You - Tales from the Corporate Frontlines: The Worth of Health Insurance
This article relates to the Compensation and Benefits Competency, commonly evaluated in employee satisfaction surveys. The questions included in this competency will help your org According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product anization determine whether your employees feel they are fairly paid for the work they perform when compared to a similar job at a different company. This competency also queries ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in heir feelings regarding the adequacy and quality of their benefits package. A fair and attractive compensation package is critical for hiring and retaining quality employees. A hi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. gh satisfaction level in this competency requires that your compensation structure and benefits package be fair, balanced, and understood by your present employees. This article, here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe The Worth of Health Insurance, is part of AlphaMeasure's compilation, Tales from the Corporate Frontlines. It focuses specifically on the value of employer provided health insuran d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e to employees in today's workplace and economic climate. Anonymous Submission: Large salary increases are rare these days, especially for mid level, mid career employees ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc . Having worked at the same small, family owned business for about ten years now, my fellow employees and I were accustomed to getting about the same raise every year. It never va easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ied very much, and we considered it fair, especially since the business was quite solid and successful with a steady profit stream for the past several years. That's why we were nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically all so shocked this year when our expected increase amount was cut in half. After the shock faded, the office was abuzz with speculation "the company is going under, that sales re and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ , Mr. Brown, lost that lucrative account, I knew this would happen, the owners are just getting greedy, they're thinking of selling to a large multinational" - were some of the st ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ries considered. Finally, our general manager caught wind of the discussions and settled us down for a meeting. He told us that the reason the increases had been cut was that the ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a health insurance program premiums had risen very sharply. The owners decided that rather than require the employees to pay more for the insurance, it would be better to pay the e dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod tra premium and give smaller salary increases. He told us that many companies are handling rising premiums in much the same way. Many employees, myself included, were skeptical. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Sure, we told each other. That's a good story. And we picked up where we'd left off with our previous speculations. That night, I received a phone call. It was my sister, and she tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen was crying. She's a stay- at- home mom, her husband has been downsized, and the family is at the point where it has to pay for health insurance. As my sister tearfully recited the t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rates she'd been quoted, I was beyond shock. It amounted to a small fortune. After she hung up, I went online to my health insurance provider website. I checked the rate I would p ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ay without my employer contribution. The price difference was far higher than my raise reduction, and the coverage wasn't as good. Humbled, I went to work the next day and told m y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products coworkers what I'd discovered. We'd all underestimated the worth of a solid benefit plan with good health insurance in today's workplace and economy. Suddenly our salary increase . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de seemed a lot larger. ------------------------------------------------------------- © 2005 AlphaMeasure, Inc. - All Rights Reserved This article may be reprinted elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip provided it is published in its entirety, includes the author bio information, and all links remain active. ------------------------------------------------------------ tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Most Important Management Skill
|